ChargePoint Holdings, Inc. (CHPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

ChargePoint Holdings, Inc. (CHPT) is projected to report a $1.20 per share loss for the quarter ended July 2025, an expected 40% year-over-year earnings improvement despite a 12.7% revenue decline to $94.8 million, with results due September 3. However, a 0% Earnings ESP and a Zacks Rank of #4 (Sell) suggest a low probability of beating consensus estimates. This outlook is compounded by the company having missed EPS forecasts in three of its last four quarters, indicating potential stock volatility around the release.

Analysis

ChargePoint Holdings (CHPT) is approaching its July 2025 quarterly report with a challenging outlook, characterized by conflicting fundamental signals. The consensus estimate projects a significant 12.7% year-over-year revenue decline to $94.8 million, indicating potential top-line pressure or a slowdown in market demand. In contrast, the expected loss per share of $1.20 represents a 40% improvement from the prior year, suggesting some progress in operational efficiency or cost management. However, predictive indicators are bearish: the stock holds a Zacks Rank of #4 (Sell) and a neutral Earnings ESP of 0%, a combination that historically makes an earnings beat difficult to predict. This is further substantiated by the company's poor track record, having missed EPS estimates in three of the last four quarters, including a notable -20% negative surprise in its most recent report. While the consensus EPS estimate has seen a marginal 0.54% upward revision in the past month, this is insufficient to offset the more powerful negative signals.

Key Decisions for Investors

• Given the Zacks #4 (Sell) rating, 0% Earnings ESP, and a history of missing estimates, investors should be prepared for potential downside volatility as statistical indicators point to a low probability of a positive earnings surprise.
• Investors should scrutinize management's forward-looking guidance and commentary on the 12.7% revenue contraction, as this will be more critical for assessing the company's fundamental health than the headline improvement in loss per share.
• Considering the combination of negative predictive metrics and recent underperformance, initiating new long positions ahead of the September 3rd earnings release carries elevated risk.